Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway

Fig. 3

Trends in testing for Pneumocystis jirovecii by PCR. Number of respiratory samples referred to the Department of Medical Microbiology of St. Olavs hospital for P. jirovecii detection by PCR during the study period (grey columns) and number of respiratory samples resulting positive (black columns). *PCR was introduced in late 2006, and there was a 3.3-fold increase in testing from 2007 to 2017 in our regional referral laboratory. The mean proportion of positive samples (not depicted) was 20.8% (SD 4.7). **In 2017 Molde hospital, a local hospital in the health region, established PCR detection for P. jirovecii too. That year an additional 70 respiratory samples were tested at their laboratory, and 20 (28.6%), representing 17 patients, resulted positive (not depicted). PCR, polymerase chain reaction

Back to article page